In addition to its pivotal role in inflammation-related diseases, RETN was shown to suppress the miR-186-5p levels, thereby contributing to cancer resistance in ovarian cancer[55] and facilitating VEGF-C-associated lymphangiogenesis in human chondrosarcoma cells[56]. This evidence concerns the gene RETN and ovarian cancer.